TipRanks
NeoPharm Co., Ltd. (KR:092730)
:092730
South Korea Market
092730
NeoPharm Co., Ltd.
RESEARCH TOOLSreports
Want to see KR:092730 full AI Analyst Report?

NeoPharm Co., Ltd. (092730) Balance Sheet

― Followers

NeoPharm Co., Ltd. Balance Sheet

NeoPharm Co., Ltd.'s total assets for Q1 2026 were ₩225.35B, an increase of 2.30% from the previous quarter. KR:092730 total liabilities were ₩33.24B for the fiscal quarter, a 33.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
₩ 220.28B₩ 192.44B₩ 177.46B₩ 155.35B₩ 143.41B
Total Liabilities
₩ 24.92B₩ 15.56B₩ 17.43B₩ 13.14B₩ 13.10B
Total Equity Gross Minority
₩ 195.36B₩ 176.88B₩ 160.03B₩ 142.21B₩ 130.30B
Other Metrics
Currency in KRW

NeoPharm Co., Ltd. Debt to Assets